![Karin Hoogendoorn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karin Hoogendoorn
Direktor/Vorstandsmitglied bei Centre For Advanced Medical Products
Aktive Positionen von Karin Hoogendoorn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Centre For Advanced Medical Products | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Karin Hoogendoorn
Ehemalige bekannte Positionen von Karin Hoogendoorn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IDOGEN AB (PUBL) | Direktor/Vorstandsmitglied | - | 12.05.2020 |
ELICERA THERAPEUTICS AB | Direktor/Vorstandsmitglied | 01.01.2021 | - |
Independent Dir/Board Member | 01.01.2021 | - | |
Janssen Biologics BV
![]() Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Corporate Officer/Principal | - | - |
NOVARTIS AG | Corporate Officer/Principal | - | - |
MENDUS AB | Corporate Officer/Principal | 13.02.2017 | - |
Ausbildung von Karin Hoogendoorn
University of Leiden | Graduate Degree |
University of Utrecht | Doctorate Degree |
Statistik
International
Schweden | 5 |
Niederlande | 4 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Graduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
MENDUS AB | Health Technology |
IDOGEN AB (PUBL) | Health Technology |
NOVARTIS AG | Health Technology |
ELICERA THERAPEUTICS AB | Health Technology |
Private Unternehmen | 2 |
---|---|
Janssen Biologics BV
![]() Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Health Technology |
Centre For Advanced Medical Products |
- Börse
- Insiders
- Karin Hoogendoorn
- Erfahrung